A naukri.com initiative
Bioengineer
2w
359
Image Credit: Bioengineer
Sarcopenia Predicts Cancer Mortality: New Models
- A study published in BMC Cancer reveals the detrimental impact of sarcopenia, muscle loss, on mortality in cancer patients.
- Sarcopenia has been identified as a crucial clinical concern in oncology beyond its traditional association with aging populations.
- Researchers utilized data from NHANES to study over a thousand cancer patients diagnosed between 1999 and 2014.
- Sophisticated prediction models were developed to project patient outcomes over three and five years, incorporating advanced statistical techniques and machine learning.
- Sarcopenia was found to increase the hazard of all-cause death by 33% and the risk of cancer-related mortality by 67%.
- The study validated five machine learning algorithms for survival prediction, with LightGBM showing superior performance.
- Machine learning algorithms like LightGBM enable precise risk assessments in oncology, assisting in personalized patient care.
- The integration of machine learning in survival models represents a shift towards individualized medicine and more accurate predictions.
- The study advocates for the inclusion of sarcopenia assessment in routine clinical practice to improve treatment outcomes and survival.
- The findings underline the importance of addressing muscle health in cancer care for better quality of life and survival chances.
Read Full Article
21 Likes
For uninterrupted reading, download the app